• Hover over video and click the volume icon for sound

Welcome to the Colorado State University

Research Innovation Center

Amenities

  • Meeting rooms
  • Break rooms
  • Reception
  • Mail service
  • CSU electronic library system access
  • Access to vivarium, laboratory animal services, and major equipment cores for mass spectrometry and next generation sequencing

Space

  • Total Area: 17,000 sq. ft.
  • Total Office Area: 1,700 sq. ft.
  • Total Lab Area: 7,500 sq. ft.
  • 21 Labs: 140 – 700 sq. ft.
  • Located at the CSU Foothill campus
  • Office space located next to flexible, BSL-2 wet lab space
  • High security facility, monitored 24x7

Features

  • Discounted fee structure for use of university major equipment core facilities and instrumentation (next generation sequencing, proteomics)
  • Eligibility to hire CSU student interns, paid for by CSU
  • Life science business advisory services available
  • Ideal location for establishing collaborative R&D relationships with world-class CSU faculty

Current Tenant Companies

Armis Biopharma is a late-stage clinical biopharmaceutical company with a growing pipeline of targeted anti-infective therapeutics designed to address antibiotic resistance and healthcare-associated infections, a serious and rapidly growing phenomenon.

E-Flux strives to solve environmental problems with unique and simple solutions. Products include Fossil Fuel Traps, which were conceived as a cost-effective solution to the complex problem of accurately measuring petroleum biodegredation rates in soil at petroleum spill sites. The second product offering, Map Traps, utilize similar but less sensitive testing capabilities. Map Traps are used to delineate petroleum based contaminated areas by providing a binary (yes / no) indication of the presence of petroleum. A third product, BioTherm, is a web-based thermal modeling tool used to enhance the conceptual site model.

KromaTiD, Inc. provides products and services for mutation detection and disease diagnosis. KromaTiD’s patented dGH™ chromosome imaging platform enables detection of all types of chromosomal rearrangements including previously undetectable cryptic inversions. Launched in 2013, KromaTiD’s research products and services are paving the way to a deeper understanding of genetic diseases, including cancers and developmental disorders.

  • PhotonPharma

PhotonPharma in a development stage immuno-oncology company whose technology platform combines whole-inactivated tumor cells with novel adjuvants to fight solid tumor cancers.

Creating the Most Advanced Rechargeable Battery. Battery technology has realized only single-digit improvements in performance over the last decade. Many companies are trying to improve certain parts of the lithium-ion battery technology but here at Prieto Battery, we decided to redesign the entire architecture. And so far the results have been promising, Prieto Battery is poised to commercialize a battery that will deliver transformational performance in power density, improved energy density, last longer and will be made using non-toxic chemistry.

SiVEC Biotechnologies is committed to developing antiviral products for the rapid prevention of economically important diseases. SiVEC’s patent pending antiviral technology, SiVEC-AIV™, can be rapidly applied as a large-scale aerosol to prevent avian flu in poultry, thereby significantly reducing the economic impact of this disease worldwide.

VeriPrime Research Division has been actively engaged in researching oxidative stress in feedlot cattle for over four years, and just recently in dairy cattle. Oxidative stress encompasses the effect of environment, nutrition, stage of production, muscle accretion, milk production, and management practices on the overall production of metabolic toxins and their impact on redox equilibrium within cellular systems. Disruption of the normal redox equilibrium leads to cellular damage, apoptosis, DNA damage, and detrimental changes in cellular messenger systems, all of which contribute to disease, distress, and inefficient production of meat and milk. 

Vivaldi Biosciences is a clinical-stage biotechnology company developing live attenuated influenza vaccines (LAIVs) to address the most pressing public health issues of influenza: the need for a rapid and effective response to emerging pandemics with vaccines that are easily administered, safe and protective, and the need for vaccines that protect the most vulnerable populations – seniors and young children – against seasonal influenza. These age groups suffer disproportionately from influenza and its serious complications, but are poorly served by conventional influenza vaccines.

Interested in Applying for a Space?

Fill out an application and email to idrc-coordinator@colostate.edu